Clinical Trial Update: Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating pyrazoloacridine with stem cell or bone marrow transplantation in young patients with high-risk disseminated or recurrent neuroblasto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Pyrazoloacridine (pyrazoloacridine)
• Stem cell transplantation (bone marrow transplantation)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Disseminated Neuroblastoma, Recurrent Neuroblastoma | Phase 1 | Status: TERMINATED